Skip to Main content Skip to Navigation
Journal articles

Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project

Michèle Beau-Faller 1 Erwan Pencreach 2 Charlotte Leduc 3 Hélène Blons 4 Jean-Philippe Merlio 5 Pierre-Paul Bringuier 6 Florence de Fraipont 7 Fabienne Escande 8 Antoinette Lemoine 9 l'Houcine Ouafik 10, 11 Marc Denis 12 Paul Hofman 13 Roger Lacave 14 Samia Melaabi 15 Alexandra Langlais 16 Pascale Missy 16 Franck Morin 16 Denis Moro-Sibilot 17 Fabrice Barlesi 18 Jacques Cadranel 19
Complete list of metadatas

https://hal-amu.archives-ouvertes.fr/hal-02483277
Contributor : l'Houcine Ouafik <>
Submitted on : Tuesday, February 18, 2020 - 3:18:51 PM
Last modification on : Friday, May 29, 2020 - 4:50:03 PM

Identifiers

Citation

Michèle Beau-Faller, Erwan Pencreach, Charlotte Leduc, Hélène Blons, Jean-Philippe Merlio, et al.. Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project. Lung Cancer, Elsevier, 2020, 140, pp.19-26. ⟨10.1016/j.lungcan.2019.10.013⟩. ⟨hal-02483277⟩

Share

Metrics

Record views

55